Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes - PubMed (original) (raw)
Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes
T Wölfel et al. Eur J Immunol. 1994 Mar.
Abstract
A number of cytolytic T lymphocyte (CTL) clones derived from several melanoma patients have been found to recognize a majority of melanomas from HLA-A2 patients. We have reported previously that two such CTL clones recognize a product of the tyrosinase gene that is presented by HLA-A2. Here we show that one of these CTL clones recognizes a peptide encoded by the first nine amino acids of the putative signal sequence of tyrosinase. The other CTL clone recognizes a different tyrosinase peptide corresponding to amino acids 368-376. Both peptides contain consensus motifs of HLA-A2 binding peptides.
Similar articles
- A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes.
Brichard VG, Herman J, Van Pel A, Wildmann C, Gaugler B, Wölfel T, Boon T, Lethé B. Brichard VG, et al. Eur J Immunol. 1996 Jan;26(1):224-30. doi: 10.1002/eji.1830260135. Eur J Immunol. 1996. PMID: 8566071 - Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
Valmori D, Pittet MJ, Vonarbourg C, Rimoldi D, Liénard D, Speiser D, Dunbar R, Cerundolo V, Cerottini JC, Romero P. Valmori D, et al. Cancer Res. 1999 Aug 15;59(16):4050-5. Cancer Res. 1999. PMID: 10463606 - A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.
van der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boël P, De Smet C, Traversari C, Townsend A, Boon T. van der Bruggen P, et al. Eur J Immunol. 1994 Dec;24(12):3038-43. doi: 10.1002/eji.1830241218. Eur J Immunol. 1994. PMID: 7805731 - Genes coding for tumor antigens recognized by human cytolytic T lymphocytes.
Coulie PG, Weynants P, Lehmann F, Herman J, Brichard V, Wölfel T, Van Pel A, De Plaen E, Brasseur F, Boon T. Coulie PG, et al. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):104-9. doi: 10.1097/00002371-199308000-00004. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8280701 Review. - Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines.
Van den Eynde B, Gaugler B, van der Bruggen P, Coulie P, Brichard V, Boon T. Van den Eynde B, et al. Biochem Soc Trans. 1995 Aug;23(3):681-6. doi: 10.1042/bst0230681. Biochem Soc Trans. 1995. PMID: 8566443 Review. No abstract available.
Cited by
- Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms.
Alarcon NO, Jaramillo M, Mansour HM, Sun B. Alarcon NO, et al. Pharmaceutics. 2022 Jul 11;14(7):1448. doi: 10.3390/pharmaceutics14071448. Pharmaceutics. 2022. PMID: 35890342 Free PMC article. Review. - Neoantigen-Reactive T Cells: The Driving Force behind Successful Melanoma Immunotherapy.
Davis L, Tarduno A, Lu YC. Davis L, et al. Cancers (Basel). 2021 Dec 1;13(23):6061. doi: 10.3390/cancers13236061. Cancers (Basel). 2021. PMID: 34885172 Free PMC article. Review. - HLA-DRB1_∗_16:01 and HLA-DQB1_∗_05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma.
Wang X, Almazan F, Montoyo-Pujol YG, Martin-Casares A, Martin A, Cabrera T, López-Nevot MA. Wang X, et al. J Oncol. 2021 Sep 30;2021:3801143. doi: 10.1155/2021/3801143. eCollection 2021. J Oncol. 2021. PMID: 34630564 Free PMC article. - Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers.
Balhorn R, Balhorn MC. Balhorn R, et al. Oncotarget. 2020 Sep 1;11(35):3315-3349. doi: 10.18632/oncotarget.27709. eCollection 2020 Sep 1. Oncotarget. 2020. PMID: 32934776 Free PMC article. - Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model.
Mac Keon S, Bentivegna S, Levy EM, Marks MS, Mantegazza AR, Wainstok R, Mordoh J. Mac Keon S, et al. Vaccine. 2019 Aug 14;37(35):4947-4955. doi: 10.1016/j.vaccine.2019.07.018. Epub 2019 Jul 13. Vaccine. 2019. PMID: 31307876 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials